A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs TRC 101 (Primary)
  • Indications Acidosis; Kidney disorders; Renal failure
  • Focus Adverse reactions; First in man
  • Sponsors Tricida
  • Most Recent Events

    • 09 Jan 2017 Topline results published in a Tricida media release.
    • 05 Dec 2016 Status changed from recruiting to completed.
    • 27 Sep 2016 Change in treatment arms from 4 to 6 with increase in patient numbers from 101 to 130.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top